Deutsche Bank’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$487K Buy
33,830
+12,204
+56% +$176K ﹤0.01% 2458
2025
Q1
$149K Sell
21,626
-5,252
-20% -$36.2K ﹤0.01% 3049
2024
Q4
$143K Buy
26,878
+25,412
+1,733% +$135K ﹤0.01% 3162
2024
Q3
$5.35K Hold
1,466
﹤0.01% 3462
2024
Q2
$4K Buy
+1,466
New +$4K ﹤0.01% 3438
2022
Q2
Sell
-26,525
Closed -$66K 4165
2022
Q1
$66K Sell
26,525
-3,018
-10% -$7.51K ﹤0.01% 3678
2021
Q4
$110K Buy
29,543
+1,502
+5% +$5.59K ﹤0.01% 3611
2021
Q3
$176K Sell
28,041
-866
-3% -$5.44K ﹤0.01% 3597
2021
Q2
$285K Sell
28,907
-154,955
-84% -$1.53M ﹤0.01% 3547
2021
Q1
$1.72M Buy
183,862
+99,655
+118% +$931K ﹤0.01% 2280
2020
Q4
$404K Buy
84,207
+5,798
+7% +$27.8K ﹤0.01% 3027
2020
Q3
$314K Buy
78,409
+19,858
+34% +$79.5K ﹤0.01% 2910
2020
Q2
$269K Buy
58,551
+44,553
+318% +$205K ﹤0.01% 2950
2020
Q1
$46K Sell
13,998
-828
-6% -$2.72K ﹤0.01% 3511
2019
Q4
$63K Sell
14,826
-9,716
-40% -$41.3K ﹤0.01% 3751
2019
Q3
$96K Sell
24,542
-5,399
-18% -$21.1K ﹤0.01% 3503
2019
Q2
$139K Sell
29,941
-18,640
-38% -$86.5K ﹤0.01% 3936
2019
Q1
$202K Sell
48,581
-1,719
-3% -$7.15K ﹤0.01% 3906
2018
Q4
$171K Sell
50,300
-36,941
-42% -$126K ﹤0.01% 3852
2018
Q3
$375K Buy
87,241
+13,394
+18% +$57.6K ﹤0.01% 3871
2018
Q2
$274K Buy
73,847
+17,293
+31% +$64.2K ﹤0.01% 4046
2018
Q1
$237K Buy
56,554
+33,608
+146% +$141K ﹤0.01% 3986
2017
Q4
$134K Buy
22,946
+22,874
+31,769% +$134K ﹤0.01% 3970
2017
Q3
$0 Sell
72
-48,055
-100% ﹤0.01% 4526
2017
Q2
$183K Buy
48,127
+41,153
+590% +$156K ﹤0.01% 3819
2017
Q1
$18K Sell
6,974
-11,082
-61% -$28.6K ﹤0.01% 4171
2016
Q4
$58K Buy
18,056
+13,347
+283% +$42.9K ﹤0.01% 4046
2016
Q3
$14K Buy
4,709
+234
+5% +$696 ﹤0.01% 4236
2016
Q2
$18K Buy
+4,475
New +$18K ﹤0.01% 4442